Evolution of the Average Target: GlaxoSmithKline Pakistan Limited

Evolution of the Target Price: GlaxoSmithKline Pakistan Limited

Changes in Analyst Recommendations: GlaxoSmithKline Pakistan Limited

509f.4wUAJ2vbGU_WBJj192bcm2_UxHzMIFKNFh0gruvgcYE.0mRqChq_eD-TW8qWhBCxqFqgr021VBvIY1t3wLHRO_CtbnUTGqtNfaZTyQ~07dbff49ca238cfa45a3857dfc79d899

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +50.54%
+11.96%
+1.66%
+8.26%
+3.24%
+0.76%
+31.03%
-10.16%
+4.82%
+8.05%
Average +11.02%
Weighted average by Cap. +7.26%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
338.78PKR
Average target price
510.00PKR
Spread / Average Target
+50.54%
High Price Target
510.00PKR
Spread / Highest target
+50.54%
Low Price Target
510.00PKR
Spread / Lowest Target
+50.54%

Analyst Consensus Detail

Consensus revision (last 18 months)

  1. Stock Market
  2. Stocks
  3. GLAXO Stock
  4. Consensus GlaxoSmithKline Pakistan Limited